Plasma microRNAs are promising novel biomarkers for the early detection of Toxoplasma gondii infection

Parasites and Vectors

Volumn 7, Issue 1, 2014, Pages

  Jia, Boyin ^a   Chang, Zhiguang ^a   Wei, Xiaoyan ^a   Lu, Huijun ^a   Yin, Jigang ^a   Jiang, Ning ^a   Chen, Qijun ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Biomarker; MicroRNAs; Plasma; Real time PCR; Toxoplasma gondii

Indexed keywords

MICRORNA; BIOLOGICAL MARKER; MIRN-217 MICRORNA, MOUSE; MIRN511 MICRORNA, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; FEMALE; GENE EXPRESSION; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PLASMODIUM BERGHEI INFECTION; PLASMODIUM CHABAUDI INFECTION; PLASMODIUM YOELII INFECTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS INFECTION; TOXOPLASMOSIS; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; DISEASE MODEL; EARLY DIAGNOSIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; TOXOPLASMA;

TOXOPLASMA GONDII;

ANIMALS; BIOMARKERS; DISEASE MODELS, ANIMAL; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, INBRED BALB C; MICRORNAS; TOXOPLASMA; TOXOPLASMOSIS; UP-REGULATION;

EID: 84908457659     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-7-433     Document Type: Article

References (39)

1. Dubey J: Toxoplasma, Hammondia, Besnotia, Sarcosystis, and Other Tissue Cyst-Forming Coccidia of Man and Animals, Volume 3. New York: Academic Press; 1977:101-237.
2. Dubey J, Beattie C: Toxoplasmosis of Animals and Man. Boca Raton: CRC Press; 1988:220.
3. Sun X, Lu H, Jia B, Chang Z, Peng S, Yin J, Chen Q, Jiang N: A comparative study of Toxoplasma gondii seroprevalence in three healthy Chinese populations detected using native and recombinant antigens. Parasit Vectors 2013, 6(1):241.
4. Fan CK, Lee LW, Liao CW, Huang YC, Lee YL, Chang YT, da Costa Ados S, Gil V, Chi LH, Nara T: Toxoplasma gondii infection: relationship between seroprevalence and risk factors among primary schoolchildren in the capital areas of Democratic Republic of Sao Tome and Principe, West Africa. Parasit Vectors 2012, 5:141.
5. Sauer A, de la Torre A, Gomez-Marin J, Bourcier T, Garweg J, Speeg-Schatz C, Candolfi E: Prevention of retinochoroiditis in congenital toxoplasmosis: Europe versus South America. Pediatr Infect Dis J 2011, 30(7):601-603.
6. Bossi P, Caumes E, Astagneau P, Li TS, Paris L, Mengual X, Katlama C, Bricaire F: Epidemiologic characteristics of cerebral toxoplasmosis in 399 HIV-infected patients followed between 1983 and 1994. Rev Med Interne 1998, 19 (5):313-317.
7. Gao XJ, Zhao ZJ, He ZH, Wang T, Yang TB, Chen XG, Shen JL, Wang Y, Lv FL, Hide G, Lun ZR: Toxoplasma gondii infection in pregnant women in China. Parasitology 2012, 139(2):139-147.
8. Karczewski G, Golab E: Diagnostic problems with congenital toxoplasmosis. Przegl Epidemiol 2011, 65(3):451-454.
9. Gilbert R: Treatment for congenital toxoplasmosis: finding out what works. Mem Inst Oswaldo Cruz 2009, 104(2):305-311.
10. Contini C: Clinical and diagnostic management of toxoplasmosis in the immunocompromised patient. Parassitologia 2008, 50(1-2):45-50.
11. Sensini A: Toxoplasma gondii infection in pregnancy: opportunities and pitfalls of serological diagnosis. Clin Microbiol Infect 2006, 12(6):504-512.
12. Lin MH, Chen TC, Kuo TT, Tseng CC, Tseng CP: Real-time PCR for quantitative detection of Toxoplasma gondii. J Clin Microbiol 2000, 38(11):4121-4125.
13. Toth T, Sziller I, Papp Z: PCR detection of Toxoplasma gondii in human fetal tissues. Methods Mol Biol 1998, 92:195-202.
14. Guy EC, Pelloux H, Lappalainen M, Aspock H, Hassl A, Melby KK, Holberg-Pettersen M, Petersen E, Simon J, Ambroise-Thomas P: Interlaboratory comparison of polymerase chain reaction for the detection of Toxoplasma gondii DNA added to samples of amniotic fluid. Eur J Clin Microbiol Infect Dis 1996, 15(10):836-839.
15. Van Rooij E, Marshall WS, Olson EN: Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circ Res 2008, 103(9):919-928.
16. Xu MJ, Zhou DH, Huang SY, Zhao FR, Nisbet AJ, Lin RQ, Song HQ, Zhu XQ: Comparative characterization of microRNA profiles of different genotypes of Toxoplasma gondii. Parasitology 2013, 140(9):1111-1118.
17. Wang J, Liu X, Jia B, Lu H, Peng S, Piao X, Hou N, Cai P, Yin J, Jiang N, Chen Q: A comparative study of small RNAs in Toxoplasma gondii of distinct genotypes. Parasit Vectors 2012, 5:186.
18. Xu MJ, Zhou DH, Nisbet AJ, Huang SY, Fan YF, Zhu XQ: Characterization of mouse brain microRNAs after infection with cyst-forming Toxoplasma gondii. Parasit Vectors 2013, 6(1):154.
19. Xiao J, Li Y, Prandovszky E, Karuppagounder SS, Talbot CC Jr, Dawson VL, Dawson TM, Yolken RH: MicroRNA-132 dysregulation in Toxoplasma gondii infection has implications for dopamine signaling pathway. Neuroscience 2014, 268:128-138.
20. Cai Y, Chen H, Jin L, You Y, Shen J: STAT3-dependent transactivation of miRNA genes following Toxoplasma gondii infection in macrophage. Parasit Vectors 2013, 6:356.
21. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008, 105(30):10513-10518.
22. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS, Sung JJ: Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009, 58(10):1375-1381.
23. Silva J, Garcia V, Zaballos A, Provencio M, Lombardia L, Almonacid L, Garcia JM, Dominguez G, Pena C, Diaz R, Herrera M, Varela A, Bonilla F: Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival. Eur Respir J 2011, 37(3):617-623.
24. Morimura R, Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Nagata H, Konishi H, Shiozaki A, Ikoma H, Okamoto K, Ochiai T, Taniguchi H, Otsuji E: Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. Br J Cancer 2011, 105(11):1733-1740.
25. Shen J, Hruby GW, McKiernan JM, Gurvich I, Lipsky MJ, Benson MC, Santella RM: Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer. Prostate 2012, 72(13):1469-1477.
26. Caggana M, Conroy JM, Pass KA: Rapid, efficient method for multiplex amplification from filter paper. Hum Mutat 1998, 11(5):404-409.
27. Homan WL, Vercammen M, De Braekeleer J, Verschueren H: Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR. Int J Parasitol 2000, 30(1):69-75.
28. Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S: The current state of serum biomarkers of hepatotoxicity. Toxicology 2008, 245(3):194-205.
29. Amacher DE, Adler R, Herath A, Townsend RR: Use of proteomic methods to identify serum biomarkers associated with rat liver toxicity or hypertrophy. Clin Chem 2005, 51(10):1796-1803.
30. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Roxe T, Muller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S: Circulating microRNAs in patients with coronary artery disease. Circ Res 2010, 107(5):677-684.
31. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS, Harris AL: Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008, 141(5):672-675.
32. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A: Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 2011, 57(6):833-840.
33. Son DJ, Kumar S, Takabe W, Kim CW, Ni CW, Alberts-Grill N, Jang IH, Kim S, Kim W, Won Kang S, Baker AH, Woong Seo J, Ferrara KW, Jo H: The atypical mechanosensitive microRNA-712 derived from pre-ribosomal RNA induces endothelial inflammation and atherosclerosis. Nat Commun 2013, 4:3000.
34. Gui T, Zhou G, Sun Y, Shimokado A, Itoh S, Oikawa K, Muragaki Y: MicroRNAs that target Ca (2+) transporters are involved in vascular smooth muscle cell calcification. Lab Invest 2012, 92(9):1250-1259.
35. Yu L, Liao Q, Zeng X, Lv Z, Zheng H, Zhao Y, Sun X, Wu Z: MicroRNA expressions associated with eosinophilic meningitis caused by Angiostrongylus cantonensis infection in a mouse model. Eur J Clin Microbiol Infect Dis 2014, 33(8):1457-1465.
36. Tserel L, Runnel T, Kisand K, Pihlap M, Bakhoff L, Kolde R, Peterson H, Vilo J, Peterson P, Rebane A: MicroRNA expression profiles of human blood monocyte-derived dendritic cells and macrophages reveal miR-511 as putative positive regulator of Toll-like receptor 4. J Biol Chem 2011, 286(30):26487-26495.
37. Hou B, Benson A, Kuzmich L, DeFranco AL, Yarovinsky F: Critical coordination of innate immune defense against Toxoplasma gondii by dendritic cells responding via their Toll-like receptors. Proc Natl Acad Sci U S A 2011, 108(1):278-283.
38. Li H, Zhao J, Zhang JW, Huang QY, Huang JZ, Chi LS, Tang HJ, Liu GQ, Zhu DJ, Ma WM: MicroRNA-217, down-regulated in clear cell renal cell carcinoma and associated with lower survival, suppresses cell proliferation and migration. Neoplasma 2013, 60(5):511-515.
39. Zhao WG, Yu SN, Lu ZH, Ma YH, Gu YM, Chen J: The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Carcinogenesis 2010, 31(10):1726-1733.